Tessa Therapeutics
Temasek-backed Tessa Therapeutics to cease operations after failure to raise funding
TESSA Therapeutics, one of the top-funded biotech startups in Singapore, will soon enter liquidation after failing to find investors to continue funding the development of its cancer treatment cell th...
Tessa Therapeutics’ new CEO bullish on moonshot in off-the-shelf cancer therapy
The Temasek-backed company may embark on its next fundraise in Q4 or early next year.
Tessa Therapeutics appoints ex-Takeda executive as CEO
SINGAPORE biotech Tessa Therapeutics on Monday (Aug 22) named a new CEO and president, Thomas Willemsen, a former Asia-Pacific senior vice president at Japan’s Takeda Pharmaceutical Company.
Singapore’s Tessa Therapeutics raises US$126m led by Polaris Partners
The company hopes to advance 2 key programmes targeted at cancer treatment.
Cancer immunotherapy biotech Tessa Therapeutics names industry veteran to board
IN a sign that it could be progressing towards certain milestones, Singapore-based immunotherapy biotech company Tessa Therapeutics continued to shore up its board of directors with another independen...
Tessa Therapeutics to open cell therapy manufacturing facility next year
TEMASEK-BACKED biotech firm Tessa Therapeutics will open a 90,000 square foot commercial-scale cell therapy manufacturing facility in Singapore next year, it said in a press statement on Thursday.
Biotech firm Tessa Therapeutics, China-Singapore Guangzhou Knowledge City in US$120m cell therapy JV
SINGAPORE-BASED biotech company Tessa Therapeutics and China-Singapore Guangzhou Knowledge City (CSGKC) have formed a US$120 million joint venture (JV) in China to develop cell therapies for cancer.
Temasek leads funding for Tessa Therapeutics
TEMASEK Holdings, along with its investment unit Heliconia Capital and three other investors, has pumped US$80 million into Singapore-based biopharmaceutical company Tessa Therapeutics.
Biopharma Tessa Therapeutics closes US$80m Temasek-led funding round
BIOPHARMACEUTICAL company Tessa Therapeutics announced it has successfully completed a US$80 million funding round led by Singapore investment company Temasek.
Novena Global headed for Taiwan listing to raise US$150m
SINGAPORE-BASED Novena Global Lifecare Group (Novena) plans to list on the Taipei Exchange (TPEx) as part of its plan to expand regionally to meet buoyant demand from "affluent Asians to stay healthy ...
